drugset
drugset / Trial / NCT02260830

Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167

NCT02260830 ↗

Phase 1 Completed 28 enrolled H. Lundbeck A/S
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the pharmacokinetic (PK) properties of various modified release tablet formulations of Lu AF11167 (Part A) and to investigate the pharmacokinetic (PK) properties of a modified release tablet formulation of Lu AF11167 in a fed and fasted state and following multiple dosing (Part B).

Timeline

Start
2014-08
Primary completion
2015-03
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AF11167 Unknown 2 mg —

Indications

schizophrenia